| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37,661 |
32,351 |
$3.87M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,982 |
21,043 |
$2.32M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,192 |
11,666 |
$1.75M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,385 |
8,525 |
$1.39M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,500 |
5,726 |
$1.38M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,433 |
8,615 |
$1.28M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
913 |
907 |
$729K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,123 |
2,097 |
$671K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
301 |
300 |
$580K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,635 |
1,595 |
$477K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,343 |
1,324 |
$423K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,072 |
3,016 |
$421K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,028 |
3,438 |
$415K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
478 |
475 |
$394K |
| 80053 |
Comprehensive metabolic panel |
26,234 |
23,852 |
$387K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,838 |
2,324 |
$384K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,221 |
1,204 |
$345K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,903 |
1,871 |
$341K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
853 |
350 |
$329K |
| 59025 |
Fetal non-stress test |
1,931 |
1,167 |
$317K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,411 |
2,327 |
$273K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
6,017 |
5,852 |
$267K |
| 87631 |
|
3,275 |
3,212 |
$259K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,347 |
4,273 |
$256K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
3,440 |
3,378 |
$252K |
| 20610 |
|
973 |
887 |
$220K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
698 |
698 |
$215K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,306 |
1,118 |
$208K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,667 |
6,503 |
$204K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,658 |
1,836 |
$170K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,684 |
1,680 |
$169K |
| 93975 |
|
632 |
626 |
$162K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,682 |
6,516 |
$158K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
187 |
187 |
$156K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,184 |
1,975 |
$153K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
420 |
415 |
$137K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
5,721 |
2,029 |
$136K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,786 |
4,769 |
$128K |
| 99215 |
Prolong outpt/office vis |
1,178 |
1,102 |
$126K |
| 97161 |
|
1,297 |
1,284 |
$108K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,225 |
1,225 |
$105K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,822 |
2,666 |
$101K |
| 76801 |
|
1,124 |
1,042 |
$101K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,048 |
1,043 |
$98K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
466 |
465 |
$97K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,157 |
3,653 |
$96K |
| 71046 |
Radiologic examination, chest; 2 views |
2,855 |
2,801 |
$89K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,080 |
21,397 |
$85K |
| 36415 |
Collection of venous blood by venipuncture |
28,569 |
25,061 |
$83K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,683 |
9,554 |
$82K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,658 |
4,984 |
$78K |
| 80061 |
Lipid panel |
9,249 |
9,209 |
$77K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,263 |
5,732 |
$67K |
| 76830 |
Ultrasound, transvaginal |
485 |
484 |
$65K |
| 74018 |
|
1,244 |
1,208 |
$58K |
| 73564 |
|
1,159 |
1,105 |
$57K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
520 |
519 |
$55K |
| 76770 |
|
296 |
293 |
$55K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,327 |
7,287 |
$53K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
3,292 |
3,269 |
$51K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
490 |
483 |
$49K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,024 |
1,024 |
$47K |
| 73610 |
|
1,339 |
1,195 |
$46K |
| 87660 |
|
4,476 |
4,388 |
$44K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
435 |
435 |
$44K |
| 87634 |
|
1,343 |
1,329 |
$44K |
| 90715 |
|
1,589 |
1,586 |
$44K |
| 73030 |
|
1,051 |
975 |
$42K |
| 73630 |
|
1,257 |
1,160 |
$40K |
| 84702 |
|
5,159 |
4,494 |
$37K |
| 87480 |
|
4,252 |
4,168 |
$37K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
326 |
293 |
$36K |
| 87510 |
|
4,209 |
4,127 |
$36K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
70 |
70 |
$36K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,972 |
4,178 |
$35K |
| 84484 |
|
6,795 |
3,809 |
$35K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
40 |
39 |
$34K |
| 86850 |
|
2,022 |
1,961 |
$33K |
| 76536 |
|
279 |
277 |
$33K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
734 |
719 |
$33K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,282 |
5,963 |
$33K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
342 |
338 |
$32K |
| 73100 |
|
663 |
526 |
$30K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,741 |
4,399 |
$29K |
| 84439 |
|
3,759 |
3,706 |
$27K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
12 |
12 |
$27K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
232 |
232 |
$26K |
| 82607 |
|
2,544 |
2,534 |
$26K |
| 90686 |
|
1,122 |
1,121 |
$25K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,157 |
1,157 |
$24K |
| 82728 |
|
2,341 |
2,292 |
$23K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
118 |
116 |
$22K |
| 86780 |
|
2,297 |
2,270 |
$22K |
| 86803 |
|
2,588 |
2,575 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
225 |
225 |
$22K |
| 87150 |
|
753 |
749 |
$22K |
| 86900 |
|
1,958 |
1,899 |
$21K |
| 73502 |
|
481 |
448 |
$20K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
226 |
225 |
$19K |
| 81025 |
|
4,315 |
4,256 |
$19K |
| 86901 |
|
1,967 |
1,907 |
$19K |
| 83655 |
|
1,500 |
1,494 |
$17K |
| 83690 |
|
5,480 |
5,065 |
$17K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,495 |
2,441 |
$17K |
| 85027 |
|
5,000 |
4,510 |
$17K |
| 83880 |
|
566 |
544 |
$16K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
107 |
62 |
$16K |
| 87070 |
|
2,267 |
2,222 |
$16K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
280 |
250 |
$14K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
26 |
25 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
2,123 |
2,064 |
$14K |
| 87340 |
|
1,751 |
1,743 |
$13K |
| 73130 |
|
426 |
394 |
$13K |
| 86762 |
|
1,085 |
1,079 |
$12K |
| 96376 |
|
729 |
541 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
27 |
27 |
$12K |
| 83550 |
|
2,388 |
2,347 |
$11K |
| 83735 |
|
3,245 |
2,867 |
$11K |
| 85610 |
|
3,059 |
2,536 |
$11K |
| 90677 |
|
251 |
251 |
$11K |
| 83540 |
|
2,571 |
2,523 |
$11K |
| 87081 |
|
2,824 |
2,777 |
$10K |
| 87040 |
|
2,237 |
1,310 |
$10K |
| 87186 |
|
1,920 |
1,782 |
$9K |
| 72100 |
|
163 |
161 |
$9K |
| 84403 |
|
403 |
396 |
$9K |
| 81001 |
|
5,192 |
4,906 |
$9K |
| 93971 |
|
72 |
70 |
$8K |
| 73560 |
|
296 |
262 |
$8K |
| 76813 |
|
120 |
115 |
$8K |
| 73110 |
|
253 |
232 |
$8K |
| 82784 |
|
648 |
538 |
$7K |
| 83605 |
|
1,616 |
1,423 |
$7K |
| 82570 |
|
1,889 |
1,829 |
$7K |
| G0378 |
Hospital observation service, per hour |
112 |
105 |
$7K |
| 87077 |
|
1,270 |
1,112 |
$7K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
53 |
37 |
$7K |
| 80076 |
|
870 |
838 |
$7K |
| 82803 |
|
238 |
203 |
$7K |
| 73140 |
|
217 |
195 |
$7K |
| 82746 |
|
694 |
690 |
$6K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
494 |
479 |
$6K |
| 82043 |
|
1,458 |
1,454 |
$6K |
| 86140 |
|
1,881 |
1,720 |
$6K |
| 88142 |
|
245 |
245 |
$6K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
549 |
548 |
$6K |
| 76641 |
|
24 |
24 |
$5K |
| 73120 |
|
122 |
107 |
$5K |
| 84153 |
|
401 |
396 |
$5K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
43 |
42 |
$5K |
| 99385 |
|
56 |
56 |
$5K |
| 85379 |
|
1,028 |
1,010 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
563 |
498 |
$4K |
| 81003 |
|
4,149 |
3,981 |
$4K |
| 87430 |
|
826 |
818 |
$4K |
| 87088 |
|
756 |
719 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,168 |
3,292 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
536 |
481 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,362 |
2,327 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
36 |
35 |
$4K |
| 85730 |
|
1,197 |
1,173 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
25 |
25 |
$4K |
| 90651 |
|
73 |
73 |
$4K |
| 86706 |
|
468 |
467 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
188 |
187 |
$4K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$4K |
| 97162 |
|
40 |
40 |
$4K |
| 90656 |
|
172 |
172 |
$4K |
| 86038 |
|
578 |
576 |
$3K |
| 84402 |
|
149 |
146 |
$3K |
| 85652 |
|
1,982 |
1,828 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
56 |
53 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
724 |
705 |
$3K |
| 84481 |
|
278 |
277 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
494 |
433 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
363 |
339 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
679 |
539 |
$3K |
| G0008 |
Administration of influenza virus vaccine |
187 |
187 |
$2K |
| 86704 |
|
262 |
261 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
78 |
78 |
$2K |
| 86376 |
|
166 |
165 |
$2K |
| 82950 |
|
526 |
524 |
$2K |
| 73080 |
|
34 |
29 |
$2K |
| 83970 |
|
52 |
52 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
77 |
77 |
$2K |
| 83001 |
|
125 |
125 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,794 |
2,705 |
$2K |
| 84480 |
|
271 |
270 |
$2K |
| 87641 |
|
66 |
65 |
$2K |
| 99442 |
|
159 |
151 |
$2K |
| 88342 |
|
12 |
12 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,767 |
1,729 |
$2K |
| 90680 |
|
56 |
56 |
$1K |
| 73590 |
|
32 |
27 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,021 |
4,098 |
$1K |
| 86481 |
|
24 |
24 |
$1K |
| 82550 |
|
378 |
368 |
$1K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
14 |
14 |
$1K |
| 83002 |
|
76 |
76 |
$1K |
| 99173 |
|
595 |
595 |
$1K |
| 86696 |
|
83 |
83 |
$1K |
| 84550 |
|
338 |
325 |
$1K |
| 72110 |
|
24 |
24 |
$1K |
| 90697 |
|
38 |
38 |
$996.94 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,088 |
663 |
$990.77 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,661 |
1,612 |
$947.79 |
| 86141 |
|
95 |
94 |
$911.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
39 |
39 |
$883.58 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
118 |
117 |
$874.63 |
| 83520 |
|
112 |
101 |
$843.22 |
| 87147 |
|
359 |
355 |
$810.88 |
| 86431 |
|
201 |
201 |
$810.15 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
89 |
81 |
$803.81 |
| 81002 |
|
1,164 |
1,141 |
$747.41 |
| 84703 |
|
212 |
205 |
$746.86 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
354 |
345 |
$726.53 |
| 90734 |
|
56 |
56 |
$702.80 |
| 84146 |
|
40 |
40 |
$702.28 |
| 87522 |
Neg quan hep c or qual rna |
12 |
12 |
$660.96 |
| 87205 |
|
280 |
270 |
$652.39 |
| 90633 |
|
30 |
30 |
$627.50 |
| 99441 |
|
79 |
72 |
$586.24 |
| 82947 |
|
310 |
254 |
$533.04 |
| 84100 |
|
162 |
130 |
$511.34 |
| 88304 |
|
16 |
15 |
$508.42 |
| 86308 |
|
193 |
190 |
$481.76 |
| 97010 |
|
41 |
18 |
$476.90 |
| 96161 |
|
12 |
12 |
$475.44 |
| 80305 |
|
527 |
505 |
$420.11 |
| 83525 |
|
43 |
43 |
$412.16 |
| 86705 |
|
49 |
49 |
$400.08 |
| 86618 |
|
36 |
35 |
$390.53 |
| 84436 |
|
67 |
67 |
$363.41 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
992 |
897 |
$359.51 |
| 86800 |
|
25 |
25 |
$311.06 |
| J7050 |
Infusion, normal saline solution, 250 cc |
97 |
84 |
$310.04 |
| 90619 |
|
15 |
15 |
$301.20 |
| 80074 |
|
13 |
12 |
$293.37 |
| 86709 |
|
59 |
58 |
$281.33 |
| 86592 |
|
55 |
55 |
$182.45 |
| 82248 |
|
43 |
39 |
$179.07 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
62 |
61 |
$160.41 |
| 82150 |
|
65 |
64 |
$157.48 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
26 |
26 |
$134.16 |
| 83993 |
|
12 |
12 |
$125.55 |
| 99443 |
|
15 |
15 |
$120.56 |
| 83615 |
|
26 |
25 |
$111.55 |
| 86765 |
|
12 |
12 |
$109.72 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
560 |
477 |
$105.88 |
| 87449 |
|
24 |
24 |
$105.54 |
| 87272 |
|
12 |
12 |
$102.06 |
| 96127 |
|
17 |
17 |
$75.85 |
| 73562 |
|
12 |
12 |
$75.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
198 |
179 |
$69.46 |
| 84156 |
|
31 |
29 |
$61.79 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
64 |
62 |
$39.18 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
72 |
71 |
$35.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
112 |
92 |
$29.50 |
| 85018 |
|
25 |
24 |
$26.67 |
| J1630 |
Injection, haloperidol, up to 5 mg |
12 |
12 |
$4.83 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
18 |
12 |
$3.56 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
17 |
15 |
$2.87 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
67 |
64 |
$0.36 |
| 99177 |
|
25 |
25 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
109 |
91 |
$0.00 |
| A9270 |
Non-covered item or service |
575 |
501 |
$0.00 |